ATC Group: N07BA01 Nicotine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N07BA01 in the ATC hierarchy

Level	Code	Title
`1`	N	Nervous system
`2`	N07	Other nervous system drugs
`3`	N07B	Drugs used in addictive disorders
`4`	N07BA	Drugs used in nicotine dependence
`5`	N07BA01	Nicotine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount
BUCCAL	Buccal	30 mg
NASAL	Nasal	30 mg
RESPIR	Respiratory (Inhalation)	60 mg
SL	Sublingual	30 mg
T-DERMAL	Transdermal	14 mg

Active ingredients in N07BA01

Active Ingredient
Nicotine
Nicotine, the primary alkaloid in tobacco products and a naturally occurring autonomous substance, is a nicotine receptor agonist in the peripheral and central nervous systems and has pronounced CNS and cardiovascular effects.

Related product monographs

Document	Type	Information Source
NICORETTE Inhalation cartridge	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
NICORETTE INVISI Transdermal patch	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
NICOTINELL MINT Compressed lozenge	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
NIQUITIN Transdermal patch	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)